The United Laboratories International Holdings Limited
ULIHF
$1.64
-$0.1543-8.60%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.09% | 10.35% | 25.09% | 40.81% | 63.22% |
| Total Depreciation and Amortization | 6.66% | 2.56% | -2.63% | -2.56% | -2.52% |
| Total Amortization of Deferred Charges | 13.82% | 0.13% | -14.02% | -14.02% | -14.02% |
| Total Other Non-Cash Items | -342.44% | -155.66% | 8.85% | -38.89% | -60.88% |
| Change in Net Operating Assets | 112.52% | 70.46% | -46.34% | -113.04% | -179.48% |
| Cash from Operations | 28.98% | 22.91% | 15.73% | 15.47% | 15.48% |
| Capital Expenditure | -33.14% | -47.01% | -63.62% | -59.76% | -55.34% |
| Sale of Property, Plant, and Equipment | 114.46% | -6.07% | -61.75% | -53.80% | -43.37% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 91.58% | 31.03% | -260.22% | -248.83% | -242.22% |
| Cash from Investing | -10.48% | -40.68% | -92.08% | -116.07% | -151.02% |
| Total Debt Issued | 8.98% | -23.82% | -43.93% | -37.74% | -30.75% |
| Total Debt Repaid | 78.75% | 78.39% | 78.14% | 44.95% | -5.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -2,189.08% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -70.54% | -79.85% | -92.79% | -92.79% | -92.79% |
| Other Financing Activities | -34.35% | -28.44% | -17.34% | -63.22% | -116.02% |
| Cash from Financing | 142.67% | 141.68% | 140.34% | 11.14% | -12,228.53% |
| Foreign Exchange rate Adjustments | 68.59% | -46.21% | -2,935.56% | -344.09% | -220.06% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 530.95% | 1,525.65% | 147.81% | -39.88% | -131.63% |